|Expense Ratio (net)||N/A|
|Last Cap Gain||N/A|
|Morningstar Risk Rating||N/A|
|Beta (3Y Monthly)||N/A|
|5y Average Return||N/A|
|Average for Category||N/A|
CALGARY, AB / ACCESSWIRE / FEBRUARY 27, 2019 / Asia Cannabis Corp. ("ACC" or the "Company") (CSE:ASIA), announced today that it has granted an aggregate of 550,000 stock options (each, an "Option") to a director of the Company in accordance with the Company's stock option plan. Each Option is exercisable into one common share in the capital of the Company (each, a "Share") at a price of $0.25 per Share for a period of five years from the date of grant. Including this grant of Options, the Company has granted less than 100% of the Options available for grant under its stock option plan.
CALGARY, AB / ACCESSWIRE / February 21, 2019 / Asia Cannabis Corp. ("ACC" or the "Company") (CSE:ASIA), announced today that, subject to regulatory approval, Dr. Darryl Hudson has been elected as a member of the Board of Directors. Dr. Hudson is a principal of InPlanta Biotechnology Inc. and received a PhD in Molecular Biology and Genetics from the University of Guelph in 2010.
Calgary, Alberta--(Newsfile Corp. - January 11, 2019) - Asia Cannabis Corp. (CSE: ASIA) ("Asia" or the "Corporation") is pleased to announce that it has completed its initial public offering of 5,047,000 common shares at the price of $0.25 per common share pursuant to a Prospectus dated October 29, 2018 for gross proceeds of $1,261,750 (the "Offering" or the "IPO"). The Corporation will be listed as a hemp research and development company on the Canadian ...